Search Within

Philip A Watson

Formats
  1. Journal Article (20)
  2. Meeting Abstract (4)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Sloan Kettering Institute Postdocs (26)
  2. GSK Faculty (22)
  3. Department of Medicine (21)
  4. Human Oncology and Pathogenesis Program (18)
  5. Center for Hematologic Malignancies (17)
  6. Executive Committee, Center for Hematologic Malignancies (17)

More Groups

People
  1. Charles Sawyers (17)
  2. John Wongvipat (9)
  3. Anuradha Gopalan (6)
  4. Howard Scher (5)
  5. Wouter Karthaus (5)
  6. Eugine Lee (4)

More People

Years
  1. 2024 (2)
  2. 2022 (1)
  3. 2020 (4)
  4. 2019 (4)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Cancer Research (5)
  2. Cancer Discovery (2)
  3. Clinical Cancer Research (2)
  4. Nature Communications (2)
  5. Proceedings of the National Academy of Sciences of the United States of America (2)
  6. Science (2)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. Nature Publishing Group (4)
  3. American Association for the Advancement of Science (3)
  4. National Academy of Sciences (2)
  5. eLife Sciences Publications Ltd. (2)
  6. Amer Assoc Advancement Science (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
    Journal Article

    Watson, P. A.; Chen, Y. F.; Balbas, M. D.; Wongvipat, J.; Socci, N. D.; Viale, A.; Kim, K.; Sawyers, C. L.
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save
  • Molecular biology of novel targets identified through study of castration-recurrent prostate cancer
    Book Section

    Watson, P. A.; Sawyers, C. L.
    In Tindall, D.; Mohler, J. (Eds.) Androgen Action in Prostate Cancer (2009)

    Fulltext@MSK | Save
  • Development of a second-generation antiandrogen for treatment of advanced prostate cancer
    Journal Article

    Tran, C.; Ouk, S.; Clegg, N. J.; Chen, Y.; Watson, P. A.; Arora, V.; Wongvipat, J.; Smith-Jones, P. M.; Yoo, D.; Kwon, A.; more...
    Science (2009)

    Fulltext@MSK | Save
  • Evidence for an androgen receptor threshold dependency in prostate cancer cells with natural androgen receptor overexpression
    Meeting Abstract

    Watson, P. A.; Wongvipat, J.; Leung, D. H.; Sawyers, C. L.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation
    Journal Article

    Kim, K.; Brush, J. M.; Watson, P. A.; Cacalano, N. A.; Iwamoto, K. S.; McBride, W. H.
    Molecular Cancer Research (2008)

    Fulltext@MSK | Save
  • Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development
    Journal Article

    Jiao, J.; Wang, S.; Qiao, R.; Vivanco, I.; Watson, P. A.; Sawyers, C. L.; Wu, H.
    Cancer Research (2007)

    Fulltext@MSK | Save